Compounds of the form
In which Q is selected from —CH═NR
12
, —W, —CH
2
NHR
13
, —CH═O and —CH(OR
17
)
2
capable of modulating the activity of histone demethylases (HDMEs), which are useful for prevention and/or treatment of diseases in which genomic dysregulation is involved in the pathogenesis, such as e.g. cancer and formulations and methods of use of such compounds.
化合物的形式为其中Q从—CH═NR12,—W,—CH2NHR13,—CH═O和—CH(OR17)2中选择,能够调节组蛋白去甲基化酶(H
DMEs)的活性,这些化合物对于预防和/或治疗
基因组失调参与病理生理学的疾病,例如癌症,以及这些化合物的制剂和使用方法是有用的。